We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$280M
AUM Growth
+$10.8M
Cap. Flow
+$9.98M
Cap. Flow %
3.57%
Top 10 Hldgs %
39.43%
Holding
168
New
48
Increased
41
Reduced
29
Closed
33

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$11M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.56M
3
WEC icon
WEC Energy
WEC
+$5.59M
4
LHX icon
L3Harris
LHX
+$4.44M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 36.56%
2 Financials 11.47%
3 Industrials 9.71%
4 Consumer Discretionary 9.38%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMO icon
101
Domo
DOMO
$189M
$231K 0.08%
32,570
+13,777
+73% +$111K
UCTT
102
Ultra Clean Holdings
UCTT
$3.83B
$226K 0.08%
6,278
+975
+18% +$36.1K
VRNS icon
103
Varonis Systems
VRNS
$4.84B
$224K 0.08%
+5,052
New +$263K
VKTX icon
104
Viking Therapeutics
VKTX
$4B
$204K 0.07%
5,061
+821
+19% +$46.8K
CMT icon
105
Core Molding Technologies
CMT
$225M
$189K 0.07%
+11,413
New +$188K
EYE icon
106
National Vision
EYE
$1.79B
$182K 0.07%
17,511
+2,475
+16% +$27.1K
SNCY
107
DELISTED
Sun Country Airlines
SNCY
$154K 0.06%
+10,569
New +$143K
CMRX
108
DELISTED
Chimerix, Inc.
CMRX
$154K 0.06%
44,305
+8,134
+22% +$11.5K
DBRG icon
109
DigitalBridge
DBRG
$2.95B
$148K 0.05%
13,116
+2,408
+22% +$32.4K
CTOS icon
110
Custom Truck One Source
CTOS
$2.46B
$146K 0.05%
30,335
+5,478
+22% +$24.8K
SEMR
111
DELISTED
Semrush
SEMR
$135K 0.05%
+11,374
New +$153K
TTI icon
112
TETRA Technologies
TTI
$1.31B
$128K 0.05%
35,674
+6,684
+23% +$23.7K
IMNM icon
113
Immunome
IMNM
$2.91B
$123K 0.04%
+11,554
New +$140K
PTLO icon
114
Portillo's
PTLO
$327M
$118K 0.04%
12,605
+2,396
+23% +$27.4K
TERN
115
DELISTED
Terns Pharmaceuticals
TERN
$114K 0.04%
+20,603
New +$140K
VMD icon
116
Viemed Healthcare
VMD
$355M
$113K 0.04%
14,120
+2,559
+22% +$22.2K
NVRI icon
117
Enviri
NVRI
$613M
$108K 0.04%
13,985
+2,412
+21% +$20.1K
AHRT
118
AH Realty Trust
AHRT
$504M
$107K 0.04%
+10,481
New +$114K
EHAB
119
DELISTED
Enhabit
EHAB
$98K 0.04%
12,533
+2,308
+23% +$17.6K
SGMT icon
120
Sagimet Biosciences
SGMT
$593M
$94K 0.03%
20,836
+3,780
+22% +$19.1K
NEXT icon
121
NextDecade
NEXT
$1.79B
$91K 0.03%
+11,776
New +$75.4K
EGAN icon
122
eGain
EGAN
$204M
$90K 0.03%
14,409
+2,771
+24% +$14.7K
ZBIO
123
Zenas BioPharma
ZBIO
$1.97B
$90K 0.03%
+10,955
New +$171K
HCAT icon
124
Health Catalyst
HCAT
$129M
$77K 0.03%
+10,893
New +$86.8K
PGEN icon
125
Precigen
PGEN
$2.45B
$77K 0.03%
68,681
+12,063
+21% +$10.3K

Similar funds

Stoneridge Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Stoneridge Investment Partners held 168 positions worth $280M, up 4% from $269M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Stoneridge Investment Partners deployed $9.98M of net new capital in Q4 2024, opening 48 new positions and adding to 41 existing holdings. Its largest new stake was Chubb: 27,680 shares worth $7.65M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was General Motors, an estimated $3.69M trimmed.

  • Stoneridge Investment Partners's largest Q4 2024 buy was Chubb: 27,680 shares worth $7.65M.
  • Stoneridge Investment Partners added most to CVS Health in Q4 2024, an estimated $8.54M increase.
  • Stoneridge Investment Partners's biggest Q4 2024 reduction was General Motors, cutting an estimated $3.69M.
  • Stoneridge Investment Partners fully exited Wells Fargo in Q4 2024, selling an estimated $11M.
  • Stoneridge Investment Partners's ten largest holdings make up 39% of its $280M portfolio in Q4 2024.
  • Stoneridge Investment Partners opened 48 new positions and closed 33 in Q4 2024.
  • Stoneridge Investment Partners's portfolio value rose 4% quarter-over-quarter to $280M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2024, filed 28 Jan 2025.